Chuck Cleland
Charles M. Cleland, PhD
CDUHR - Co-Director, Transdisciplinary Research Methods Core
NYU Langone Health - Associate Professor, Department of Population Health
PhD, Psychology, New School for Social Research
MA, Psychology, New School for Social Research
BA, Psychology, Hampden-Sydney College

Research Interests
HIV prevention, Health disparities, Substance use, Sexual health, Longitudinal data analysis
Charles Cleland is a quantitative psychologist and biostatistician with more than ten years of experience in the field of public health research. His methodological interests include longitudinal data analysis, meta­-analysis, respondent­ driven sampling, and multilevel modeling. His substantive research interests include health disparities, particularly in the areas of substance use and infectious disease.


Gwadz M, Cleland CM, Lizardo M, Hawkins RL, Bangser G, Parameswaran L, Stanhope V, Robinson JA, Karim S, Holloway T, Ramirez PG, Filippoine PL, Ritchie AS, Banfield A, Silverman E (2022).
Using the multiphase optimization strategy (MOST) framework to optimize an intervention to increase COVID-19 testing for Black and Latino/Hispanic frontline essential workers: A study protocol
BMC Public Health, 22, 1235. doi: 10.1186/s12889-022-13576-0.

Barnes DM, Xu S, Cleland CM, McKnight C, Des Jarlais D (2022).
Recurrent injecting drug use as a mediator between psychiatric disorder and non-fatal overdose
Substance Use and Misuse, 57 (8), 1248-1256. doi: 10.1080/10826084.2022.2076877.

Feiring C, Liang E, Cleland C, Simon V (2022).
Romantic conflict narratives and associations with psychological relationship aggression in emerging adult couples
Journal of Social and Personal Relationships, 39 (5), 1529-1548. doi: 10.1177/02654075211059538.

Levy NS, Palamar JJ, Mooney SJ, Cleland CM, Keyes KM (2022).
What is the prevalence of drug use in the general population? Simulating underreported and unknown use for more accurate national estimates
Annals of Epidemiology, 68, 45-53. doi: 10.1016/j.annepidem.2021.12.013.

Khan MR, Brewer R, Abrams J, Mazumdar M, Scheidell JD, Feelemyer J, Dyer TV, Turpin RE, Hucks-Ortiz C, Gaydos CA, Severe M, Irvine NM, Kaufman JS, Cleland CM, Mayer KH (2022).
Incarceration and sexual risk behavior and incident STI/HIV in HPTN 061: Differences by study city and among Black sexual minority men who have sex with men, Black sexual minority men who have sex with men and women, and Black transgender women
Sexually Transmitted Diseases, 49 (4), 284-296. doi: 10.1097/OLQ.0000000000001594.


Kurth AE, Spielberg F, Cleland CM, Lambdin B, Bangsberg DR, Frick PA, Severynen AO, Clausen M, Norman RG, Lockhart D, Simoni JM, Holmes KK (2014).
Computerized counseling reduces HIV-1 viral load and sexual transmission risk: Findings from a randomized controlled trial
Journal of Acquired Immune Deficiency Syndromes, 65 (5), 611-620. doi: 10.1097/QAI.0000000000000100. PMCID: PMC3999203.

Marsch LA, Guarino H, Acosta M, Aponte-Melendez Y, Cleland C, Grabinski M, Brady R, Edwards J (2014).
Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment
Journal of Substance Abuse Treatment, 46 (1), 43-51. doi: 10.1016/j.jsat.2013.08.012. PMCID: PMC3839618 .

Rosenblum A, Joseph H, Fong, C, Kipnis S, Cleland CM, Portenoy RK (2003).
Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities
Journal of the American Medical Association, 289 (18), 2370-2378. doi: 10.1001/jama.289.18.2370.

Dr. Cleland's Research Gate Profile
Selected Press